The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...
Britain will invest up to $767 million into a new health data research service to help boost scientific studies and cut the ...
MT Newswires on MSN8h
European Equities Traded in the US as American Depositary Receipts Drop in Monday TradingContinuing their decline from last week, European equities traded in the US as American depositary receipts were sharply lower late Monday morning, falling 1.73% to 1,257.11 on the S&P Europe Select ...
After fighting for us to get our fair share, I am pleased that East Worthing and Shoreham will receive almost £1.5m of ...
The UK will invest up to £600 million into a new health data research service to enhance scientific studies and accelerate ...
South Korean clinical-stage biotech ABL Bio (Kosdaq: 298380) on Sunday announced a worldwide licensing agreement enabling GSK ...
GSK's clinical-stage pipeline is currently focused on oncology, respiratory, immunology and inflammation, and infectious ...
ABL Bio Inc. (KOSDAQ: 298380), a clinical-stage biotech company developing bispecific antibody technology for immuno-oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback